3.4850
-0.0650
(-1.83%)
At close: January 31 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12,476.0000
-12,476.0000
-37,103.0000
-29,872.0000
-27,538.0000
Investing Cash Flow
-349.0000
-349.0000
138.0000
-242.0000
-112.0000
Financing Cash Flow
46,771.0000
46,771.0000
-5,651.0000
-5,180.0000
111,769.0000
End Cash Position
75,283.0000
75,283.0000
41,388.0000
83,921.0000
119,151.0000
Capital Expenditure
-337.0000
-337.0000
-93.0000
-233.0000
-107.0000
Issuance of Capital Stock
60,154.0000
60,154.0000
--
--
113,650.0000
Issuance of Debt
150.0000
150.0000
--
--
10,350.0000
Repayment of Debt
-3,765.0000
-3,765.0000
-4,735.0000
-3,742.0000
-1,178.0000
Free Cash Flow
-12,813.0000
-12,813.0000
-37,196.0000
-30,105.0000
-27,645.0000
12/31/2020 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PSTV Plus Therapeutics, Inc.
1.2400
0.00%
GNFT Genfit S.A.
3.7300
-4.60%
MEB.BE Medincell SA
15.72
+1.81%
NVV1.BE Novavax Inc
8.62
+2.49%
AKESF Akeso, Inc.
7.10
0.00%
MLYS Mineralys Therapeutics, Inc.
10.30
+0.29%
IPHA Innate Pharma S.A.
1.8300
+4.57%
STTK Shattuck Labs, Inc.
1.1600
-7.20%
EPRX.TO Eupraxia Pharmaceuticals Inc.
4.4500
+2.06%
DRTSW Alpha Tau Medical Ltd.
0.3900
+11.05%